These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1306309)

  • 1. The molecular biology of lung cancer.
    Gazdar AF
    Tohoku J Exp Med; 1992 Oct; 168(2):239-45. PubMed ID: 1306309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular and cellular basis of human lung cancer.
    Gazdar AF
    Anticancer Res; 1994; 14(1B):261-7. PubMed ID: 8166465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular genetics of small cell lung carcinoma.
    Wistuba II; Gazdar AF; Minna JD
    Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenes in human lung cancer.
    Kratzke RA; Shimizu E; Kaye FJ
    Cancer Treat Res; 1992; 63():61-85. PubMed ID: 1363367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetic abnormalities in premalignant lung lesions: biological and clinical implications.
    Niklinski J; Niklinska W; Chyczewski L; Becker HD; Pluygers E
    Eur J Cancer Prev; 2001 Jun; 10(3):213-26. PubMed ID: 11432708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of oncogenes and suppressor genes in lung cancer and bronchial lesions from high risk group].
    Awaya Y; Hiyama K; Yamakido M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Dec; 30 Suppl():39-41. PubMed ID: 1306237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genetic abnormalities in lung cancer and their prognostic implications].
    Mitsudomi T; Takahashi T
    Gan To Kagaku Ryoho; 1996 Jul; 23(8):990-6. PubMed ID: 8687234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of genetic and molecular events in the pathogenesis of lung cancer.
    Johnson BE; Kelley MJ
    Chest; 1993 Jan; 103(1 Suppl):1S-3S. PubMed ID: 8380130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis.
    Dosaka-Akita H; Hu SX; Fujino M; Harada M; Kinoshita I; Xu HJ; Kuzumaki N; Kawakami Y; Benedict WF
    Cancer; 1997 Apr; 79(7):1329-37. PubMed ID: 9083154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers.
    Kishimoto Y; Sugio K; Hung JY; Virmani AK; McIntire DD; Minna JD; Gazdar AF
    J Natl Cancer Inst; 1995 Aug; 87(16):1224-9. PubMed ID: 7563168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetic characterization of neuroendocrine lung cancer cell lines.
    Lai SL; Brauch H; Knutsen T; Johnson BE; Nau MM; Mitsudomi T; Tsai CM; Whang-Peng J; Zbar B; Kaye FJ
    Anticancer Res; 1995; 15(2):225-32. PubMed ID: 7762988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dominant oncogenes and tumor suppressor genes in the pathogenesis of lung cancer.
    Viallet J; Minna JD
    Am J Respir Cell Mol Biol; 1990 Mar; 2(3):225-32. PubMed ID: 1968750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular abnormalities in lung cancer.
    Salgia R; Skarin AT
    J Clin Oncol; 1998 Mar; 16(3):1207-17. PubMed ID: 9508209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene amplification in human lung cancer. The myc family genes and other proto-oncogenes and growth factor genes.
    Bergh JC
    Am Rev Respir Dis; 1990 Dec; 142(6 Pt 2):S20-6. PubMed ID: 2174659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular genetics of human lung cancer.
    Slebos RJ; Rodenhuis S
    Eur Respir J; 1989 May; 2(5):461-9. PubMed ID: 2547647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenes and antioncogenes in lung tumorigenesis.
    Giaccone G
    Chest; 1996 May; 109(5 Suppl):130S-134S. PubMed ID: 8635391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.
    Girard L; Zöchbauer-Müller S; Virmani AK; Gazdar AF; Minna JD
    Cancer Res; 2000 Sep; 60(17):4894-906. PubMed ID: 10987304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic markers for early detection of lung cancer and outcome measures for response to chemoprevention.
    Wiest JS; Franklin WA; Drabkin H; Gemmill R; Sidransky D; Anderson MW
    J Cell Biochem Suppl; 1997; 28-29():64-73. PubMed ID: 9589350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of K-ras, p53, and erbB-2/neu in human lung adenocarcinomas.
    Bongiorno PF; Whyte RI; Lesser EJ; Moore JH; Orringer MB; Beer DG
    J Thorac Cardiovasc Surg; 1994 Feb; 107(2):590-5. PubMed ID: 7905543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [2000 Standards, Options and Recommendations for prognostic value of oncogenes and tumor suppressor genes in non small cell lung cancer].
    Bréchot JM; Molina T; Theobald S; Depierre A; Lagrange JL; Astoul P; Baldeyrou P; Bardet E; Bazelly B; Breton JL; Douillard JY; Grivaux M; Jacoulet P; Khalil A; Lemarié E; Martinet Y; Massard G; Milleron B; Moro-Sibilot D; Paesmans M; Pujol JL; Quoix AE; Ranfaing E; Rivière A; Sancho-Garnier H; Souquet PJ; Spaeth D; Stcebner-Delbarre A;
    Bull Cancer; 2002 Oct; 89(10):857-67. PubMed ID: 12441277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.